Robitussin manufacturer, Haleon, is voluntarily recalling eight lots of its cough syrup due to microbial contamination, the manufacturer announced Wednesday.
There have been no reports of adverse events related to this recall, Haleon said in its statement.
The recall includes six lots of Robitussin Honey CF Max Day Adult, 4 oz. and 8 oz., and two lots of Robitussin Honey CF Max Adult, in 8 oz.
One lot of daytime cough syrup in 4 oz. was recalled, T10810, which expires on Oct. 31, 2025. Five lots of daytime cough syrups in 8 oz. were recalled, including T08730, T08731, T08732 and T08733, all of which expire on May 31, 2025; lot number T10808 expires on Sept. 30, 2025.
The two lots of nighttime cough syrup recalled, T08740 and T08742, both expire June 30, 2026.
Haleon said people with these products should stop consuming them immediately, and the company said it is notifying distributors and customers directly of the microbial contamination and is providing instructions on how to return the recalled products.
The potential effects from ingesting the contaminated product would be especially severe for immunocompromised individuals, for whom “the use of the affected product could potentially result in severe or life-threatening adverse events such as fungemia or disseminated fungal infection.”
“In non-immunocompromised consumers, the population most likely to use the product, life-threatening infections are not likely to occur. However, the occurrence of an infection that may necessitate medical intervention cannot be completely ruled out,” the statement continued.
Haleon encouraged consumers to contact their healthcare providers with any problems and to report “adverse reactions or quality problems” to the Food and Drug Administration (FDA).
